Penumbra
PEN
#1732
Rank
S$14.95 B
Marketcap
S$381.87
Share price
3.15%
Change (1 day)
14.10%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.49 Billion

According to Penumbra's latest financial reports the company's total liabilities are S$0.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.51 B4.25%
2023-12-31S$0.49 B-0.07%
2022-12-31S$0.49 B27.07%
2021-12-31S$0.39 B60.2%
2020-12-31S$0.24 B0.8%
2019-12-31S$0.24 B92.15%
2018-12-31S$0.12 B24.02%
2017-12-31S$0.10 B68.97%
2016-12-31S$60.36 M36.22%
2015-12-31S$44.31 M-74.93%
2014-12-31S$0.17 B76.1%
2013-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Inari Medical
NARI
S$0.34 B-31.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
S$1.42 B 185.63%๐Ÿ‡บ๐Ÿ‡ธ USA